OPA1 and breast carcinoma: In addition, researchers found that upregulation of OPA1 expression was associated with poor prognosis in breast cancer, and the research team reduced proliferation, migration, and invasion of breast cancer cells in vitro and in vivo by inhibiting OPA1 expression.